PLUS1
AVITA Medical Financial Data
| Company name: | Avita Medical Ltd | Status: | Active |
| End of fiscal year: | 30 June 2018 | ISIN | AU000000AVH4 |
| Year established: | 1992 | Company sector name: | Healthcare |
| Trading currency: | AUD | Industry name: | Medical Devices |
| Place of incorporation: | Australia (AU) | Industry group name | Medical Devices |
| Doing business in: | United States (US) | Address | 28159 Avenue Stanford Suite 220, 91355 |
| Tel.: | +1 833 462-8482 | City/Country: | Valencia, United States |
| Web address: | http://www.avitamedical.com |
| Company description: | Avita Medical Ltd is engaged in the medical devices business sector. It is engaged in developing and distributing regenerative products for the treatment of a range of wounds, scars, and skin defects. The company’s lead product ReCell is used in the treatment of a variety of burns, plastic, reconstructive and cosmetic procedures. The company operates through geographic segments that include the Asia Pacific, Americas, and Europe, Middle East and Africa (EMEA). |
| Price | Price change [%] | Bid | Offer | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 3.90 | -0.02[-0.51%] | 3.88 | 3.90 | 3.88 | 3.92 | 3.88 | 6,067 |
| Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
| 3662.50483536 | 1864.439575 | 1.34 | -0.02 | - | -221.47 | - | 3.50 - 7.40 |
AVH KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 3.92 |
PE Ratio | -221.47 |
Market Capitalisation | 3.66B |
Latest Shares Outstanding | 1.86B |
Earnings pS (EPS) | -0.02 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | 30.04k |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | 1,203.95% |
Research & Devlopment (R&D) as ... | 0.00% |
Gross Profit Margin | 57.33% |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | 13.93% |
Return on Assets (ROA) | -1.07% |
Return on Equity (ROE) | -1.37% |
Return on Capital Invested (ROC... | -1.35% |
Current Ratio | 5.74 |
Leverage Ratio (Assets/Equity) | 1.21% |
Interest Cover | -672.46 |
Total Debt/Equity (Gearing Rati... | 0.01% |
LT Debt/Total Capital | 0.01% |
Working Capital pS | 0.02 |
Cash pS | 0.02 |
Book-Value pS | 0.02 |
Tangible Book-Value pS | 0.00 |
Cash Flow pS | - |
Free Cash Flow pS | -0.02 |
Spread | 0.02 |
Gross gearing | 0.00% |
Net Debt | -14.83M |
AVH Balance Sheet Chart (30 June 2018) | ||
|---|---|---|
 | ||
| Period † | High | Low |
|---|---|---|
| 1 Week | 4.19 | 3.50 |
| 1 Month | 5.30 | 3.50 |
| 3 Months | 5.48 | 3.50 |
| 6 Months | 5.89 | 3.50 |
| 1 Year | 7.40 | 3.50 |
| 3 Years | 9.11 | 0.077 |
| 5 Years | 9.11 | 0.046 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| Period † | Open | Open Avg. | VWAP | Min Vol | Max Vol | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|---|
| 1 Week | 4.17 | 4.064 | 4.02 | 76,314 | 498,919 | 242,248 | -0.27 | -6.47% |
| 1 Month | 4.43 | 4.4475 | 4.57 | 76,314 | 1,168,596 | 303,307 | -0.53 | -11.96% |
| 3 Months | 5.40 | 4.7093 | 4.80 | 65,842 | 3,062,750 | 384,230 | -1.50 | -27.78% |
| 6 Months | 4.65 | 4.9314 | 5.01 | 65,842 | 3,062,750 | 388,520 | -0.75 | -16.13% |
| 1 Year | 6.13 | 5.2419 | 5.42 | 65,842 | 4,491,282 | 494,357 | -2.23 | -36.38% |
| 3 Years | 0.084 | 3.1976 | 0.75848 | 59,692 | 112,291,975 | 5,602,624 | 3.82 | 4,542.86% |
| 5 Years | 0.135 | 1.9208 | 0.644479 | 23 | 112,291,975 | 3,980,600 | 3.77 | 2,788.89% |
AVH Growth Ratios (30 June 2018) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | 1.06 | 0.19 | -0.12 | -0.19 |
Revenue growth | 0.40 | -0.16 | -0.10 | 0.03 |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | 0.40 | -0.16 | -0.10 | 0.03 |
AVH Income Statement 30 June 2018 (AUD) | |
|---|---|
Total Revenue | 1.652161 |
Operating Revenue | 1.652161 |
Cost of Revenue | 0.704972 |
Gross Profit | 0.947189 |
Operating Expenses | 28.544572 |
Selling,General and Administr... | 19.891124 |
General and Administrative Ex... | 10.954684 |
Salary and Benefit | 1.835157 |
OtherGandA | 9.119527 |
Selling and Marketing Expense | 8.93644 |
Research and Development | 8.653448 |
Operating Income | -27.597383 |
Interest Income/Expense,Net-N... | 0.03907 |
Interest Income-Non Operating | 0.065656 |
Interest Expense-Non Operatin... | 0.026586 |
Other Income/Expense,Net | 9.653744 |
Other Non-Operating Income/Ex... | 9.653744 |
Pretax Income | -17.904569 |
Provision for Income Tax | -1.420369 |
Net Income Available to Commo... | -16.4842 |
Net Income | -16.4842 |
Net Income Including Noncontr... | -16.4842 |
Net Income from Continuing Op... | -16.4842 |
Basic EPS | -0.02 |
Basic EPS from Continuing Ope... | -0.02 |
Basic EPS from Discontinued O... | 0.00 |
Diluted EPS | -0.02 |
Diluted EPS from Continuing O... | -0.02 |
Diluted EPS from Discontinued... | 0.00 |
Basic Weighted Average Shares... | 934.312458 |
Diluted Weighted Average Shar... | 934.312458 |
Net Income from Continuing an... | -16.4842 |
Normalized Income | -16.4842 |
Basic EPS,Continuing and Disc... | -0.02 |
Diluted EPS,Continuing and Di... | -0.02 |
Interest and Dividend Income | 0.065656 |
Interest Expense | 0.026586 |
Net Interest Income | 0.03907 |
Earning Before Interest and T... | -17.877983 |
Earning Before Interest Tax D... | -17.877983 |
Cost of Revenue,Reconciled | 0.704972 |
Net Income from Continuing Op... | -16.4842 |
Normalized Basic EPS | -0.02 |
Normalized Diluted EPS | -0.02 |
NormalizedEBITDA | -17.877983 |
Tax rate for calculations | 0.08 |
AVH Efficency Ratios (30 June 2018) | |
|---|---|
Days in sales | 629.23 |
Days in inventory | 567.80 |
Days in payment | 1,159.15 |
Cash conversion cycle | 37.88 |
Receivable turnover | 0.58 |
Inventory turnover | 0.64 |
Payable turnover | 0.31 |
Fixed assets turnover | 2.92 |
Assets turnover | 0.11 |
ROE | -1.37 |
ROA | -1.07 |
ROIC | -1.35 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | 0.30 |
AVH Financial Health Ratios (30 June 2018) | |
|---|---|
Current ratio | 5.74 |
Quick ratio | 5.22 |
Debt total capital ratio | 0.01 |
Debt equity ratio | 0.01 |
Financial leverage | 1.21 |
Total debt to equity | 0.01 |
AVH Avearge Growth Ratios Over 5 Years (30 June 2018) | |
|---|---|
Growth ann capital spending | 0.43 |
Growth ann gross profit | -0.15 |
Avg gross margin | 0.64 |
Avg post tax margin | -6.40 |
Avg pre tax marginr | -7.60 |
Avg net profit | -6.40 |
Avg ret commonr | -1.36 |
Avg ret assets | -1.04 |
Avg ret invested capital | -1.37 |
AVH Profitability Ratios (30 June 2018) | |
|---|---|
Gross margin | 0.57 |
Operating margin | -16.70 |
EBT margin | -10.84 |
Tax rate | - |
Net margin | -9.98 |
Sales per employee | 30,039.29 |
EBIT margin | -10.82 |
EBITDA margin | -10.82 |
Normalized net profit margin | -9.98 |
Interest coverage | -672.46 |
Inc per employee tot ops | - |
AVH Valuation Ratios (29 June 2018) | |
|---|---|
Sales per share | 0.00 |
Growth ann sales per share 5 ye... | -0.37 |
Book value per share | 0.01 |
CF per share | -0.01 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 6.05 |
Price to sales | 39.37 |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | -2.37 |
Cash return | -0.20 |
AVH Balance Sheet 30 June 2018 (AUD) | |
|---|---|
Total Assets | 23.017014 |
Current Assets | 22.274431 |
Cash,Cash Equivalents,and Sho... | 14.825532 |
Cash and Cash Equivalents | 14.825532 |
Cash | 14.825532 |
Receivables | 5.437357 |
Accounts Receivable | 5.437357 |
Inventories | 1.155826 |
Prepaid Assets and Others | 0.855716 |
Total Non-Current Assets | 0.742583 |
Net Property,Plant,and Equipm... | 0.742583 |
Gross Property,Plant,and Equi... | 0.742583 |
Machinery,Furniture/Equipment | 0.742583 |
Total Liabilities | 4.017455 |
Current Liabilities | 3.883117 |
Payables and Accrued Expenses | 3.487582 |
Payables | 3.487582 |
Accounts Payable | 3.487582 |
Provisions,Current | 0.395535 |
Total Non-Current Liabilities | 0.134338 |
Long Term Debt and Capital Le... | 0.134338 |
Long Term Portion of Capital ... | 0.134338 |
Total Equity | 18.999559 |
Stockholder's Equity | 18.999559 |
Capital Stock | 162.801028 |
Common Stock | 162.801028 |
Retained Earnings | -148.592879 |
Accumulated Gains/ Losses Not... | 4.79141 |
Other Equity Adjustments | 4.79141 |
Total Capitalization | 18.999559 |
Common Stock Equity | 18.999559 |
Capital Lease Obligations | 0.134338 |
Net Tangible Assets | 18.999559 |
Working Capital | 18.391314 |
Invested Capital | 18.999559 |
Tangible Book Value | 18.999559 |
Total Debt | 0.134338 |
Ordinary Shares Number | 1277.378325 |
TotalLiabilitiesAsReported | 4.017455 |
TotalEquityAsReported | 18.999559 |
AVH Cash Flow 30 June 2018 (AUD) | |
|---|---|
Classes of Cash Receipts from... | 9.270253 |
Receipts from Customers | 1.582345 |
Other Cash Receipts from Oper... | 7.687908 |
Classes of Cash Payments | -25.681347 |
Payments to Suppliers for Goo... | -25.681347 |
Interest Paid, Direct | -0.026586 |
Interest Received, Direct | 0.065656 |
Cash Flow from Investing Acti... | -0.498749 |
Cash Flow from Continuing Inv... | -0.498749 |
Purchase/Sale of Property,Pla... | -0.498749 |
Purchase of Property,Plant an... | -0.498749 |
Cash Flow from Financing Acti... | 27.93492 |
Cash Flow from Continuing Fin... | 27.93492 |
Issuance/Payments of Common S... | 27.93492 |
Proceeds or Issuance of Commo... | 29.760563 |
Payments for Common Stock | -1.825643 |
Cash and Cash Equivalents,End... | 14.825532 |
Change in Cash | 11.064147 |
Effect of Exchange Rate Chang... | -0.029106 |
Cash and Cash Equivalents,Beg... | 3.790491 |
Interest Paid, Supplemental D... | 0.026586 |
Capital Expenditure | -0.498749 |
Issuance of Capital Stock | 29.760563 |
Repurchase of Capital Stock | -1.825643 |
Free Cash Flow | -16.870773 |
ChangeinCashSupplementalAsRep... | 11.064147 |
